Prompt actions halt alarming infection outbreak at Dallas hospital

Jul 13, 2010

Rapid identification and aggressive infection control measures allowed a Dallas hospital to stop the spread of Acinetobacter baumannii, a type of bacteria that has become increasingly prevalent in healthcare facilities and is resistant to most antibiotics. The findings were presented today at the 37th Annual Conference and International Meeting of the Association for Professionals in Infection Control and Epidemiology (APIC).

Methodist Dallas Medical Center identified an unusual cluster of drug-resistant Acinetobacter during a one-week period in 2009 and conducted an immediate investigation. Through rapid response and comprehensive interventions, the hospital was able to arrest the outbreak in a much shorter time-frame compared with most other reported outbreaks of this bacterium that have been known to last for months or years.

Infection control staff at the 515-bed hospital, in consultation with the Hospital Epidemiologist, Dr. Zakir Shaikh, quickly concluded that the known cases met the criteria for full epidemiological investigation and began an aggressive campaign of surveillance and intervention. All current and incoming patients were tested for Acinetobacter, and in affected units, every patient was put under contact precautions—where staff is required to don gloves and gowns upon entry to the patient's room, and visitors are encouraged to do the same. The hospital also instituted regular meetings between all of the departments involved with caring for these patients; administrators, physicians, nurses, lab technicians, environmental services and physical plant staff were all consulted to control the outbreak.

"A responsive hospital administration including a CEO who supports our program, close contact with local and state health departments, and collaborative teamwork between departments were responsible for our success," said Beth Wallace, MPH, CIC, infection preventionist at Methodist Dallas Medical Center who presented the findings at the APIC conference. "Our experience shows that controlling Acinetobacter outbreaks requires effective surveillance, dedicated teamwork and rapid intervention with application of best practices in a consistent and timely manner."

Acinetobacter baumannii is a species of gram-negative bacteria that has caused outbreaks of infection in healthcare facilities over the last decade and considerable concern in the medical community. Infections from this pathogen primarily occur in very ill, wounded or immunocompromised patients. The germ can remain on wet or dry surfaces for longer than most other organisms, making it harder to eradicate. As is the case with other, more well-known healthcare-associated infections, such as MRSA, Acinetobacter has effectively developed resistance to most common antibiotics and continues to evolve against the medicines used to fight its infections. Though much literature on the topic has been published in the last five years, there are no agreed-upon prevalence, morbidity or mortality figures for the infection.

"Methodist Health System makes infection prevention a priority and has the fully recommended infection prevention resources and staffing in all of their facilities," said Wallace. "Because we have adequate resources in terms of staffing and technology, we were able to keep a close eye on this and act quickly."

"With outbreaks of pan-resistant Acinetobacter baumannii and other multi-drug resistant organisms on the rise, it is absolutely essential that infection prevention departments be fully staffed and adequately resourced," said APIC President Cathryn Murphy, RN, PhD, CIC. "Methodist Dallas Medical Center was proactive in their approach, responding rapidly and mobilizing an interdisciplinary team to control the outbreak. The experiences of infection preventionists such as Ms. Wallace serve as practical guidance for healthcare professionals combating multi-drug resistant pathogens. Their experience is a powerful reminder that aggressive infection prevention programs are required to protect patients and save lives."

Wallace presented an abstract on her facility's experiences at APIC's Annual Conference. The meeting, which is the largest annual gathering of infection preventionists from around the world, takes place July 11-15 in New Orleans.

Related Stories

A type of bacterium widely found on our skin and in the environment has now become a major threat in hospitals where it can cause serious infections, such as pneumonia in severely ill patients. Like the well known bacterium ...

The Association for Professionals in Infection Control and Epidemiology (APIC) today announced a detailed strategy to combat Clostridium difficile-associated disease (CDAD). The initiative begins with the first national prevalence ...

Hospitals that adopt advanced computer technology to identify healthcare-associated infections (HAIs) are more likely to have implemented best practices to prevent such infections, according to research presented today at ...

US soldiers in Iraq do not carry the bacteria responsible for difficult-to-treat wound infections found in military hospitals treating soldiers wounded in Iraq, according to an article to be published electronically on Wednesday, ...

The recent emergence of multidrug resistance (MDR) in Acinetobacter baumannii, a bacteria that causes infections primarily among seriously ill patients in the intensive care unit who may have reduced immune systems, has ra ...

A new study in the journal Infection Control and Hospital Epidemiology reports a surge in drug-resistant strains of Acinetobacter, a dangerous type of bacteria that is becoming increasingly common in U.S. hospitals. This ...

Recommended for you

(HealthDay)—For patients with facet joint arthropathy, platelet-rich plasma (PRP) has a short-term positive impact, according to a study presented at the annual meeting of the American Academy of Pain Medicine, ...

Both traditional and HIV-related risk factors can predict the likelihood of developing chronic kidney disease (CKD), according to a study published this week in PLOS Medicine. In the study, Amanda Mocroft, of University Colleg ...

New research at the University of Michigan offers evidence that a drug being developed to treat osteoporosis may also be useful for treating osteogenesis imperfecta or brittle bone disease, a rare but potentially debilitating ...